Oral valproic acid plus acetyl‐L‐carnitine vs placeboMuscle strength · non‐ambulatory children with SMA types II and III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 16 participantsLow